In-Hospital Observation on Oral Diuretics After Treatment for Acute Decompensated Heart Failure: Evaluating the Utility.
diuretics
heart failure
natriuresis
outpatient
patient readmission
Journal
Circulation. Heart failure
ISSN: 1941-3297
Titre abrégé: Circ Heart Fail
Pays: United States
ID NLM: 101479941
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
pmc-release:
01
04
2024
medline:
20
4
2023
pubmed:
11
3
2023
entrez:
10
3
2023
Statut:
ppublish
Résumé
Following treatment for acute decompensated heart failure, in-hospital observation on oral diuretics (OOD) is recommended, assuming it provides actionable information on discharge diuretic dosing and thus reduces readmissions. In the Mechanisms of Diuretic Resistance (MDR) cohort, we analyzed in-hospital measures of diuretic response, provider's decisions, and diuretic response ≈30 days postdischarge. In a Yale multicenter cohort, we assessed if in-hospital OOD was associated with 30-day readmission risk. The main objective of this study was to evaluate the utility of in-hospital OOD. Of the 468 patients in the MDR cohort, 57% (N=265) underwent in-hospital OOD. During the OOD, weight change and net fluid balance correlated poorly with each other ( In-hospital OOD did not provide actionable information on diuretic response, was not associated with outpatient dose selection, did not predict subsequent outpatient diuretic response, and was not associated with lower readmission rate. Additional research is needed to replicate these findings and understand if these resources could be better allocated elsewhere. URL: https://www. gov; Unique identifier: NCT02546583.
Sections du résumé
BACKGROUND
Following treatment for acute decompensated heart failure, in-hospital observation on oral diuretics (OOD) is recommended, assuming it provides actionable information on discharge diuretic dosing and thus reduces readmissions.
METHODS
In the Mechanisms of Diuretic Resistance (MDR) cohort, we analyzed in-hospital measures of diuretic response, provider's decisions, and diuretic response ≈30 days postdischarge. In a Yale multicenter cohort, we assessed if in-hospital OOD was associated with 30-day readmission risk. The main objective of this study was to evaluate the utility of in-hospital OOD.
RESULTS
Of the 468 patients in the MDR cohort, 57% (N=265) underwent in-hospital OOD. During the OOD, weight change and net fluid balance correlated poorly with each other (
CONCLUSIONS
In-hospital OOD did not provide actionable information on diuretic response, was not associated with outpatient dose selection, did not predict subsequent outpatient diuretic response, and was not associated with lower readmission rate. Additional research is needed to replicate these findings and understand if these resources could be better allocated elsewhere.
REGISTRATION
URL: https://www.
CLINICALTRIALS
gov; Unique identifier: NCT02546583.
Identifiants
pubmed: 36896716
doi: 10.1161/CIRCHEARTFAILURE.122.010206
pmc: PMC10186250
mid: NIHMS1876841
doi:
Substances chimiques
Diuretics
0
Banques de données
ClinicalTrials.gov
['NCT02546583']
Types de publication
Multicenter Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e010206Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL128973
Pays : United States
Organisme : NHLBI NIH HHS
ID : R21 HL143092
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK113191
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139629
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148354
Pays : United States
Organisme : NHLBI NIH HHS
ID : L30 HL115790
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL114868
Pays : United States
Références
Circulation. 2012 Jul 24;126(4):479-85
pubmed: 22825409
ESC Heart Fail. 2020 Dec;7(6):4458-4464
pubmed: 32893505
Circ Heart Fail. 2021 Apr;14(4):e008335
pubmed: 33866827
J Am Coll Cardiol. 2019 Oct 15;74(15):1966-2011
pubmed: 31526538
Cardiol Res. 2021 Aug;12(4):244-250
pubmed: 34349866
Eur J Heart Fail. 2019 Feb;21(2):137-155
pubmed: 30600580
JAMA. 2019 Feb 26;321(8):753-761
pubmed: 30806695
JACC Heart Fail. 2020 Jan;8(1):1-11
pubmed: 31606360
Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004365
pubmed: 30571338
J Card Fail. 2010 Jun;16(6):e1-194
pubmed: 20610207
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
Circulation. 2007 Sep 25;116(13):1482-7
pubmed: 17724259
Eur J Heart Fail. 2020 Apr;22(4):584-603
pubmed: 31908120
Eur Heart J. 2022 Feb 10;43(6):440-441
pubmed: 34922348
J Card Fail. 2014 Sep;20(9):706-7
pubmed: 24951932
JACC Heart Fail. 2017 Jan;5(1):1-13
pubmed: 28034373
J Am Coll Cardiol. 2019 Mar 12;73(9):1004-1012
pubmed: 30846093
JACC Heart Fail. 2019 May;7(5):383-391
pubmed: 31047017
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Circulation. 2013 Oct 15;128(16):e240-327
pubmed: 23741058
Circ Heart Fail. 2016 Jan;9(1):e002370
pubmed: 26721915
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
J Am Coll Cardiol. 2021 Feb 16;77(6):695-708
pubmed: 33573739
Am J Med. 2015 Jul;128(7):776-83.e4
pubmed: 25595470
JACC Heart Fail. 2020 Nov;8(11):943-953
pubmed: 32800512
Eur J Heart Fail. 2015 Mar;17(3):340-6
pubmed: 25619549
J Card Fail. 2017 Oct;23(10):746-752
pubmed: 28688888